- Home
- CRDF vs NEWP Comparison
CRDF vs NEWP Comparison
Compare CRDF & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- NEWP
- Stock Information
- Founded
- CRDF 1999
- NEWP 1972
- Country
- CRDF United States
- NEWP Canada
- Employees
- CRDF N/A
- NEWP N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- NEWP
- Sector
- CRDF Health Care
- NEWP
- Exchange
- CRDF Nasdaq
- NEWP Nasdaq
- Market Cap
- CRDF 169.6M
- NEWP 199.1M
- IPO Year
- CRDF N/A
- NEWP N/A
- Fundamental
- Price
- CRDF $3.35
- NEWP $1.44
- Analyst Decision
- CRDF Strong Buy
- NEWP Strong Buy
- Analyst Count
- CRDF 4
- NEWP 1
- Target Price
- CRDF $12.25
- NEWP $5.00
- AVG Volume (30 Days)
- CRDF 874.0K
- NEWP 266.1K
- Earning Date
- CRDF 05-08-2025
- NEWP 05-07-2025
- Dividend Yield
- CRDF N/A
- NEWP N/A
- EPS Growth
- CRDF N/A
- NEWP N/A
- EPS
- CRDF N/A
- NEWP N/A
- Revenue
- CRDF $587,000.00
- NEWP N/A
- Revenue This Year
- CRDF N/A
- NEWP N/A
- Revenue Next Year
- CRDF N/A
- NEWP N/A
- P/E Ratio
- CRDF N/A
- NEWP N/A
- Revenue Growth
- CRDF N/A
- NEWP N/A
- 52 Week Low
- CRDF $2.01
- NEWP $0.93
- 52 Week High
- CRDF $5.64
- NEWP $2.05
- Technical
- Relative Strength Index (RSI)
- CRDF 63.95
- NEWP 65.83
- Support Level
- CRDF $2.81
- NEWP $1.35
- Resistance Level
- CRDF $3.08
- NEWP $1.46
- Average True Range (ATR)
- CRDF 0.20
- NEWP 0.08
- MACD
- CRDF 0.08
- NEWP 0.02
- Stochastic Oscillator
- CRDF 76.53
- NEWP 92.86
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.